[CLINICAL AND LABORATORY FEATURES OF CHRONIC HEPATITIS C IN PATIENTS WITH HELICOBACTERIOSIS].

The aim of the study was to investigate the influence of Hp on clinical and biochemical course of chronic hepatitis C (CHC). The study included 150 patients with a confirmed diagnosis of chronic hepatitis C, who for various reasons did not receive specific antiviral therapy. Helicobacter pylori (Нр) was determined using a quick urease test (CLO-test) and a coprological test (CITO TEST, manufactured by Pharmasco LLC), interleukin (IL) levels: IL-1β, IL-6, tumor necrosis factor α (TNF-α) and neopterin by ELISA.